Dr Reddy Laboratories Ltd (RDY) Tuesday said it has launched Montelukast Sodium Tablets 10 mg and Montelukast Sodium Chewable Tablets of 4 mg and 5 mg in the US market on August 6, after the United States Food & Drug Administration approved its ANDA.
These are bioequivalent generic versions of Singulair tablets and chewable tablets. Dr. Reddy's said its Montelukast Sodium Tablets in 10 mg and Montelukast Sodium Chewable Tablets in 4 mg and 5 mg are available in bottle counts of 30 and 90.
The Singulair tablets and Chewable tablets brand had U.S. sales of around $3.6 billion and $1.14 billion, respectively, for the twelve months ending March 2012, according to IMS Health.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.